Literature DB >> 29185597

Urgent call for action: avoiding spread and re-urbanisation of yellow fever in Brazil.

Cristina Possas, Reinaldo Menezes Martins, Ricardo Lourenço de Oliveira, Akira Homma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29185597      PMCID: PMC5719535          DOI: 10.1590/0074-02760170361

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


× No keyword cloud information.
Yellow fever (YF), a haemorrhagic viral disease with a high fatality rate, is considered one of the greatest scourges of mankind. Historically, devastating epidemics of this disease have been reported since the seventeenth century in Africa, the Americas, and Europe ( WHO 2017 ). The control of urban YF in Rio de Janeiro in the beginning of the last century is recognised as one of the most successful public health initiatives in the world. Oswaldo Cruz’s successful campaigns with a strong and enforceable fight against the domestic mosquito vector Aedes aegypti dramatically dropped the number of urban YF cases in the city. The measures were applied with success across the country. The elimination of urban transmission in Brazil and all over the Americas was achieved in the early 1940’s with a combination of vaccine campaigns and Ae. aegypti eradication ( Franco 1969 ). However, the ineradicable zoonotic sylvatic transmission cycle maintained between Haemagogus and Sabethes mosquitoes and nonhuman primates (NHPs) has annually caused infections and death in humans. Importantly, YF virus (YFV) epizootics have cyclically been reported every 7-14 years in Brazil, with marked special expansion in the past decades. The last two epidemics in Brazil spanned more than one year: from 1998 to 2003, and again in 2008 and 2009, despite vaccine campaigns ( Vasconcelos 2010 , Jentes et al. 2011 , MS/SVS 2017 ). The recent sylvatic YF outbreak in Brazil has been the most severe in the last seven decades and became an epidemic. As of 31 May, 2017, a total of 3240 cases have been reported in Brazil: 792 confirmed, 1929 dismissed, and 519 remain under investigation, including 435 deaths (274 confirmed, 124 discarded, and 37 under investigation). The case fatality rate (CFR) among confirmed cases is 34.5% ( MS/SVS 2017 ). For NHPs, 3850 epizootics were reported (642 confirmed, 96 dismissed, and 1448 under investigation). The rapid spread of YF cases in Brazil has led to a major concern: infections were no longer reported just in the jungle and remote inland rural areas, but sylvatic transmission also occurred in the surroundings of the most densely populated cities in the states of São Paulo (SP), Minas Gerais (MG), Espírito Santo (ES), Bahia (BA), and Rio de Janeiro (RJ) ( MS/SVS 2017 ). It started in MG late in 2016. Despite being an area where routine immunisation is recommended and there is good vaccination coverage in the young population, the epidemic reached and hit with severity the rural area of north-eastern MG, due to poor vaccine coverage among adults. The rapid spread to the coastal state of ES, an area where YF vaccine was not routinely recommended, led to a severe epidemic with 260 confirmed cases and 85 deaths. Subsequently, the virus also spread to RJ, which also had no previous recommendation for routine YF vaccination. Fortunately, some of the areas at higher risk in RJ had already been partially vaccinated at this time. Nevertheless, 17 confirmed cases and seven deaths were recorded in the state from March to June 2017 ( MS/SVS 2017 ). The YFV circulating in Brazil since 2008 belongs to the South American Genotype I, lineage 1E ( Cardoso et al. 2010 , Souza et al. 2010 ). The whole genome of YFV causing the 2017 outbreak in ES was sequenced and phylogenetic analysis revealed that it clusters in the 1E sub-clade along with recent Brazilian and Venezuelan strains ( Mir et al. 2017 ). However, it was discovered that this virus strain displays seven new mutations, and their role in host infectivity and virus replication and spreading is still under investigation ( Bonaldo et al. 2017 ). The unique amino acid signatures carried by the 2017 YFV occur in non-structural proteins, one being a change in the capsid protein and the other in components of the viral replicase complex, the NS3 (two changes), and the NS5 (five changes) proteins; no change was detected in the envelop protein. Although the amino acid changes may affect the viral fitness, they would not potentially impact the efficacy of the available vaccines ( Bonaldo et al. 2017 ). A complex combination of ecological, social, and behavioural factors may help to explain the severity and efficient spread of the YFV in Southeast Brazil, particularly its dissemination to the Atlantic coast. Among them, ecological issues included changing environmental and climate conditions favouring a high density of competent sylvatic and urban vectors and primary amplifier vertebrate hosts (NHPs); the uncontrolled occupation of forest areas by human populations; and the large number of susceptible NHP and nonvaccinated people in peri-urban areas in close contact with forests, mainly the adult human populations from rural areas in north-eastern MG affected by the recent YFV outbreak as well as in vast coastal receptive zones ( Vasconcelos 2010 , Couto-Lima et al. 2017 ). In these zones, lack of access of populations to sanitation and garbage collection in urban areas, favouring Aedes proliferation, is contributing to an increase in the potential for re-urbanisation of YF in Brazil. YF epidemics are not acceptable and are an ethical issue. Brazil is the largest producer of the YF vaccine, which is provided free of charge. Vaccination was not recommended universally in Brazil due to the serious adverse events associated with it, 0.42 cases/100,000 administered doses in Brazil, similar to those found in Africa. In the United States, Europe, and Australia, reported rates of serious adverse events are about ten times higher. The reasons for such large differences are not clear, but intensity and quality of surveillance are crucial ( Staples et al. 2008 , Martins et al. 2010 , 2014 , MS 2014 ). Now the risk of transmission has increased, and the risk-benefit balance favours universal vaccination. This action is urgent, taking advantage of the temporary relief in YFV transmission in most of Brazil caused by the reduced rainfall and lower mean temperatures recorded during the dry season (July-October). These environmental conditions reduce the availability of mosquito larval sites, larval developmental time, mosquito adult longevity, and viral replication. YFV epizootics and human cases will potentially re-emerge in the following rainy season. The last two epidemics in Brazil spanned more than one year: from 1998 to 2003, and again in 2008 and 2009, despite vaccine campaigns ( Vasconcelos 2010 , Jentes et al. 2011 , MS/SVS 2017 ). In this aftermath, the decision by the Ministry of Health to vaccinate all the Brazilian population against YFV was obvious, and received strong support from the Brazilian scientific community and international health authorities. Due to the sudden increase in demand and limited vaccine supply, the decision by the Ministry of Health to administer only one dose of the vaccine, as recommended by the World Health Organization, was provisionally endorsable. Nevertheless, booster doses are necessary to ensure longer protection for all YFV vaccines ( CGSYF 2014 , Campi-Azevedo et al. 2016 ). Therefore, the emergency decision to administer only one dose of the vaccine recently taken by the Brazilian Ministry of Health should be re-evaluated as soon as the current sanitary situation normalises and new information on duration of immunity is available. YF vaccination needs to be urgently intensified before the next rainy season, chiefly in the states with the highest risk, such as RJ and other coastal receptive and vulnerable Brazilian zones. RJ has the largest urban forest in the world. Large remains of the Atlantic rainy forest extend in a vast territory from South to Northeast Brazil, along which millions of susceptible people live in cities, villages, and farms under the influence of this biome. Competent sylvatic mosquito vectors and susceptible NHPs are also largely distributed in this area. All together, these features render this large territory very receptive to sylvatic YFV re-emergence in the next rainy season. Alarmingly, this territory also reports high infestation by Ae. aegypti , and also of experimentally YFV-susceptible Ae. albopictus populations . The proximity with the YFV sylvatic transmission foci and the intense people movement in this territory combined with high density of these urban vectors increase the risk of YFV re-emergence in an urban cycle, which needs to be urgently prevented with vector control measures and vaccination campaigns. YF vaccination needs to be implemented for the entire Brazilian population, with specific recommendations for groups with higher risk of serious adverse events. Mobile immunisation units should be urgently provided to reach the more vulnerable rural populations who have limited access to immunisations in health centres. In addition, as the demand for YF vaccine will continue to increase due to the epidemiological context in Brazil and elsewhere, there is an urgent need to strengthen public manufacturer’s capacity to provide the YF vaccine to all who need it at an affordable price.
  10 in total

1.  Duration of post-vaccination immunity against yellow fever in adults.

Authors: 
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641

2.  Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil.

Authors:  Reinaldo de Menezes Martins; Ana Luiza Braz Pavão; Patrícia Mouta Nunes de Oliveira; Paulo Roberto Gomes dos Santos; Sandra Maria D Carvalho; Renate Mohrdieck; Alexandre Ribeiro Fernandes; Helena Keico Sato; Patricia Mandali de Figueiredo; Vanessa Dos Reis von Doellinger; Maria da Luz Fernandes Leal; Akira Homma; Maria de Lourdes S Maia
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

Review 3.  The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.

Authors:  Emily S Jentes; Gilles Poumerol; Mark D Gershman; David R Hill; Johan Lemarchand; Rosamund F Lewis; J Erin Staples; Oyewale Tomori; Annelies Wilder-Smith; Thomas P Monath
Journal:  Lancet Infect Dis       Date:  2011-08       Impact factor: 25.071

4.  Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas.

Authors:  Pedro Fernando da Costa Vasconcelos
Journal:  Rev Saude Publica       Date:  2010-10-15       Impact factor: 2.106

5.  Detection of a new yellow fever virus lineage within the South American genotype I in Brazil.

Authors:  Renato P de Souza; Peter G Foster; Maria Anice M Sallum; Terezinha L M Coimbra; Adriana Y Maeda; Vivian R Silveira; Eduardo S Moreno; Fernanda G da Silva; Iray M Rocco; Ivani B Ferreira; Akemi Suzuki; Fabíola M Oshiro; Selma M C N Petrella; Luiz E Pereira; Giselda Katz; Cilea H Tengan; Melissa M Siciliano; Cecília L S Dos Santos
Journal:  J Med Virol       Date:  2010-01       Impact factor: 2.327

6.  Yellow fever virus in Haemagogus leucocelaenus and Aedes serratus mosquitoes, southern Brazil, 2008.

Authors:  Jader da C Cardoso; Marco A B de Almeida; Edmilson dos Santos; Daltro F da Fonseca; Maria A M Sallum; Carlos A Noll; Hamilton A de O Monteiro; Ana C R Cruz; Valeria L Carvalho; Eliana V Pinto; Francisco C Castro; Joaquim P Nunes Neto; Maria N O Segura; Pedro F C Vasconcelos
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

7.  Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations.

Authors:  Dinair Couto-Lima; Yoann Madec; Maria Ignez Bersot; Stephanie Silva Campos; Monique de Albuquerque Motta; Flávia Barreto Dos Santos; Marie Vazeille; Pedro Fernando da Costa Vasconcelos; Ricardo Lourenço-de-Oliveira; Anna-Bella Failloux
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

8.  Phylodynamics of Yellow Fever Virus in the Americas: new insights into the origin of the 2017 Brazilian outbreak.

Authors:  Daiana Mir; Edson Delatorre; Myrna Bonaldo; Ricardo Lourenço-de-Oliveira; Ana Carolina Vicente; Gonzalo Bello
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

9.  Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms.

Authors:  Myrna C Bonaldo; Mariela Martínez Gómez; Alexandre Ac Dos Santos; Filipe Vieira Santos de Abreu; Anielly Ferreira-de-Brito; Rafaella Moraes de Miranda; Marcia Gonçalves de Castro; Ricardo Lourenço-de-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-06       Impact factor: 2.743

10.  Booster dose after 10 years is recommended following 17DD-YF primary vaccination.

Authors:  Ana Carolina Campi-Azevedo; Christiane Costa-Pereira; Lis R Antonelli; Cristina T Fonseca; Andréa Teixeira-Carvalho; Gabriela Villela-Rezende; Raiany A Santos; Maurício A Batista; Fernanda M Campos; Luiza Pacheco-Porto; Otoni A Melo Júnior; Débora M S H Hossell; Jordana G Coelho-dos-Reis; Vanessa Peruhype-Magalhães; Matheus F Costa-Silva; Jaquelline G de Oliveira; Roberto H Farias; Tatiana G Noronha; Jandira A Lemos; Vanessa dos R von Doellinger; Marisol Simões; Mirian M de Souza; Luiz C Malaquias; Harold R Persi; Jorge M Pereira; José A Martins; Marcos Dornelas-Ribeiro; Aline de A Vinhas; Tatiane R Alves; Maria de L Maia; Marcos da S Freire; Reinaldo de M Martins; Akira Homma; Alessandro P M Romano; Carla M Domingues; Pedro L Tauil; Pedro F Vasconcelos; Maria Rios; Iramaya R Caldas; Luiz A Camacho; Olindo Assis Martins-Filho
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

  10 in total
  18 in total

1.  Ocular Findings in Yellow Fever Infection.

Authors:  Silvana Vianello; Gláucio Silva de Souza; Maurício Maia; Rubens Belfort; João Rafael de Oliveira Dias
Journal:  JAMA Ophthalmol       Date:  2019-03-01       Impact factor: 7.389

2.  Yellow fever transmission in non-human primates, Bahia, Northeastern Brazil.

Authors:  Jaqueline Goes de Jesus; Tiago Gräf; Marta Giovanetti; Maria Angélica Mares-Guia; Joilson Xavier; Maricelia Lima Maia; Vagner Fonseca; Allison Fabri; Roberto Fonseca Dos Santos; Felicidade Mota Pereira; Leandro Ferraz Oliveira Santos; Luciana Reboredo de Oliveira da Silva; Zuinara Pereira Gusmão Maia; Jananci Xavier Gomes Cerqueira; Julien Thèze; Leandro Abade; Mirza de Carvalho Santana Cordeiro; Sintia Sacramento Cerqueira Torquato; Eloisa Bahia Santana; Neuza Santos de Jesus Silva; Rosemary Sarmento Oitiçica Dourado; Ademilson Brás Alves; Adeilde do Socorro Guedes; Pedro Macedo da Silva Filho; Nuno Rodrigues Faria; Carlos F Campelo de Albuquerque; André Luiz de Abreu; Alessandro Pecego Martins Romano; Julio Croda; Rodrigo Fabiano do Carmo Said; Gabriel Muricy Cunha; Jeane Magnavita da Fonseca Cerqueira; Arabela Leal E Silva de Mello; Ana Maria Bispo de Filippis; Luiz Carlos Junior Alcantara
Journal:  PLoS Negl Trop Dis       Date:  2020-08-11

3.  A Systematic Review: Is Aedes albopictus an Efficient Bridge Vector for Zoonotic Arboviruses?

Authors:  Taissa Pereira-Dos-Santos; David Roiz; Ricardo Lourenço-de-Oliveira; Christophe Paupy
Journal:  Pathogens       Date:  2020-04-07

Review 4.  Past, present, and future of COVID-19: a review.

Authors:  C M Romano; A Chebabo; J E Levi
Journal:  Braz J Med Biol Res       Date:  2020-07-24       Impact factor: 2.590

Review 5.  Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation.

Authors:  Cristina Possas; Ricardo Lourenço-de-Oliveira; Pedro Luiz Tauil; Francisco de Paula Pinheiro; Alcides Pissinatti; Rivaldo Venâncio da Cunha; Marcos Freire; Reinaldo Menezes Martins; Akira Homma
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-09-03       Impact factor: 2.743

6.  Confronting the Multidimensional Challenges of Research in the Context of Emerging Infectious Diseases in Brazil: The Example of Yellow Fever.

Authors:  Vivian I Avelino-Silva; Claudia Figueiredo-Mello; Luciana V B Casadio; Ana C S S Nastri; Izabel Marcilio; Ana F Ribeiro; Anna S Levin; Ester C Sabino
Journal:  Am J Trop Med Hyg       Date:  2020-03-26       Impact factor: 2.345

7.  Experimental Adaptation of the Yellow Fever Virus to the Mosquito Aedes albopictus and Potential risk of urban epidemics in Brazil, South America.

Authors:  Fadila Amraoui; Adrien Pain; Géraldine Piorkowski; Marie Vazeille; Dinair Couto-Lima; Xavier de Lamballerie; Ricardo Lourenço-de-Oliveira; Anna-Bella Failloux
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

Review 8.  What Does the Future Hold for Yellow Fever Virus? (I).

Authors:  Raphaëlle Klitting; Ernest A Gould; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-06-08       Impact factor: 4.096

9.  Potential of Aedes albopictus as a bridge vector for enzootic pathogens at the urban-forest interface in Brazil.

Authors:  Taissa Pereira Dos Santos; David Roiz; Filipe Vieira Santos de Abreu; Sergio Luiz Bessa Luz; Marcelo Santalucia; Davy Jiolle; Maycon Sebastiao Alberto Santos Neves; Frédéric Simard; Ricardo Lourenço-de-Oliveira; Christophe Paupy
Journal:  Emerg Microbes Infect       Date:  2018-11-28       Impact factor: 7.163

10.  Frozen blood clots can be used for the diagnosis of distinct Plasmodium species in man and non-human primates from the Brazilian Atlantic Forest.

Authors:  Filipe Vieira Santos de Abreu; Larissa Rodrigues Gomes; Aline Rosa Lavigne Mello; Cesare Bianco-Júnior; Anielle de Pina-Costa; Edmilson Dos Santos; Danilo Simonini Teixeira; Patrícia Brasil; Cláudio Tadeu Daniel-Ribeiro; Ricardo Lourenço-de-Oliveira; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2018-09-24       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.